首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   646篇
  免费   62篇
  国内免费   18篇
耳鼻咽喉   4篇
儿科学   17篇
妇产科学   2篇
基础医学   81篇
口腔科学   11篇
临床医学   73篇
内科学   65篇
皮肤病学   6篇
神经病学   68篇
特种医学   29篇
外科学   60篇
综合类   82篇
现状与发展   1篇
预防医学   45篇
眼科学   21篇
药学   45篇
中国医学   15篇
肿瘤学   101篇
  2024年   6篇
  2023年   22篇
  2022年   35篇
  2021年   38篇
  2020年   25篇
  2019年   19篇
  2018年   18篇
  2017年   27篇
  2016年   11篇
  2015年   26篇
  2014年   37篇
  2013年   20篇
  2012年   27篇
  2011年   38篇
  2010年   32篇
  2009年   24篇
  2008年   33篇
  2007年   28篇
  2006年   16篇
  2005年   9篇
  2004年   12篇
  2003年   24篇
  2002年   21篇
  2001年   23篇
  2000年   26篇
  1999年   20篇
  1998年   9篇
  1997年   7篇
  1996年   11篇
  1995年   5篇
  1994年   3篇
  1992年   5篇
  1991年   9篇
  1990年   4篇
  1989年   7篇
  1988年   4篇
  1987年   3篇
  1986年   3篇
  1984年   2篇
  1983年   2篇
  1982年   3篇
  1978年   4篇
  1977年   3篇
  1976年   2篇
  1975年   2篇
  1973年   3篇
  1969年   2篇
  1967年   3篇
  1965年   3篇
  1930年   1篇
排序方式: 共有726条查询结果,搜索用时 15 毫秒
1.
本文报告157例胸腰椎骨折脱位病人,非手术治疗36例,手术治疗116例。作者对临床治疗中的有关问题进行了讨论。  相似文献   
2.
小儿病毒性脑膜炎病原诊断与临床分析   总被引:9,自引:1,他引:8  
应用酶联免疫吸附(ELISA)方法,对88例临床诊断病毒性脑膜炎患儿急性期及恢复期脑脊液进行了单纯疱疹病毒(HSV-I、HSV-Ⅱ)、柯萨奇B组病毒(CoxBV)、埃可病毒(ECHO)、EB病毒(EBV)、腺病毒(AdV)及流感病毒(IFV)特异性IgM抗体检测。结果表明:HSV、CoxBV、ECHO、EBV、AdV、IFV病毒感染率分别为9.09%、18.18%、22.72%、3.41%、4.54%、5.68%;HSV及EBV感染致残率及病死率分别为87.5%(7/8)和100%(3/3)。提示脑脊液中病毒特异性IgM抗体检测可作为早期病原诊断的指标之一;CoxBV及ECH病毒是本地区小儿中枢神经系统病毒感染的主要病毒;HSV及EBV感染致残率及病死率较其它病毒高,预后不良;早期阿昔洛韦治疗,可大大降低病死率。  相似文献   
3.
①目的 了解重型病毒性肝炎病人医院感染病原微生物的分布及耐药情况。②方法 对595例重型病毒性肝炎住院病人进行医院感染的调查分析,并用分离培养法鉴定感染菌,使用E-test法进行耐药谱的检测。③结果 在595例病人中,有182例发生医院感染,感染率为30.6%,感染部位以腹腔为主,占49.7%,共分离出病原菌188株,以革兰阴性杆菌为主,占75.4%,多数感染菌对常用抗生素耐药。④结论 重型病毒性肝炎医院感染发生率较高,应引起足够重视。  相似文献   
4.
OBJECTIVE: To compare the prevalence of hereditary metabolic diseases in the native and non-native populations of Manitoba and northwestern Ontario. DESIGN: Retrospective analysis. SETTING: Children's Hospital, Winnipeg. PATIENTS: Patients were selected by three methods: laboratory tests designed to screen patients suspected of having a metabolic disease, laboratory investigation of newborn infants with abnormalities detected through screening, and investigation of near relatives of probands with disease. RESULTS: A total of 138 patients with organic acid, amino acid and carbohydrate disorders were seen from 1960 to 1990. Of these, 49 (36%) were native Indians (Algonkian linguistic group). This was in sharp contrast to the proportion of native Indians in the total study population (5.8%). Congenital lactic acidosis due to pyruvate carboxylase deficiency (13 patients), glutaric aciduria type I (14 patients) and primary hyperoxaluria type II (8 patients) were the most common disorders detected. Other rare disorders included glutaric aciduria type II (one patient), 2-hydroxyglutaric aciduria (one patient) and sarcosinemia (one patient). Underreporting, especially of glutaric aciduria type I and hyperoxaluria type II, was likely in the native population. CONCLUSIONS: Hereditary metabolic diseases are greatly overrepresented in the native population of Manitoba and northwestern Ontario. We recommend that native children who present with illnesses involving disturbances of acid-base balance or with neurologic, renal or liver disease of unknown cause by investigated for a possible metabolic disorder.  相似文献   
5.
目的:探讨莱菔硫烷(sulforaphane,SFN)对氧化低密度脂蛋白(oxidized low-density lipoprotein,ox-LDL)诱导血小板活化的影响及其可能的分子机制。方法:在体外实验中,将健康人纯化血小板与不同浓度的SFN(1.0、2.5、5.0μmol/L)共同孵育40 min,然后用ox-LDL激活血小板20 min,并检测血小板活化的指标,包括CD62P的表达、胞内血小板因子4(platelet factor4,PF4)和趋化因子配体5(chemokine ligand 5,CCL5)的释放水平。机制上,用Western blot蛋白免疫印迹法检测血小板肉瘤酪氨酸激酶(sarcoma tyrosine kinase,Src)及其下游的脾酪氨酸激酶(spleen tyrosine kinase,Syk)磷酸化水平;用活性氧(reactive oxygen species,ROS)检测试剂盒测定胞内总ROS水平。结果:ox-LDL诱导的血小板CD62P的表达以及PF4和CCL5的释放水平均可被SFN显著抑制(P <0.05);SFN显著下调ox-LD...  相似文献   
6.
Somatoform pain disorder in the general population   总被引:6,自引:0,他引:6  
BACKGROUND: Chronic pain disorder is assumed to represent a frequent and disabling condition. However, data on the prevalence of somatoform pain symptoms and somatoform pain disorder in the community are limited to date. METHODS: German versions of the Composite International Diagnostic Interview were administered to a representative national sample of 4,075 people. Somatoform pain disorder was diagnosed by standardized diagnostic algorithm based on the DSM-III-R criteria (absence of adequate physical findings). One subgroup was identified as also meeting the DSM-IV criterion B for 'significant distress or psychosocial impairment due to the somatoform pain'. RESULTS: A lifetime prevalence rate of somatoform pain disorder according to DSM-III-R of 33.7% and a 6-month rate of 17.3% was found. When applying the DSM-IV B criterion, the prevalence rate dropped to 12.3 and 5.4%, respectively. In both groups more than 95% of the probands had contacted their doctor because of the pain. In 25% of the probands the pain was positively assigned to psychological factors. A female:male ratio of 2:1 was found. CONCLUSIONS: Somatoform pain disorder (DSM-III-R) is a frequent condition. However, only about one third of these subjects is severely distressed or impaired by the pain. A clear operationalized concept of the DSM-IV criterion C 'psychological factors are judged to have an important role in the onset, severity, exacerbation or maintenance of the pain' should be provided in the further development of the diagnosis 'pain disorder' in order to make this diagnosis suitable for general population surveys.  相似文献   
7.
Summary We have ascertained the social class distribution at different care levels for a semi-rural area of southeastern Bavaria. The analysis is based on a prevalence study of psychiatric patients treated as in-and outpatients (n=3,788), a study of patients in general practices (n = 1,274) and a field study (n= 1,536). The first study is based solely on secondary statistical material (case histories); in the latter two studies, the psychiatric diagnosis was reached with the aid of the Clinical Psychiatric Interview (Goldberg et al. 1970). In classifying the psychiatric diagnoses we used the ICD (8th revision). Social class was recorded in all three samples according to the classification of Moore and Kleining (1960). During the first 6 months of 1971, psychiatric outpatients were clearly overrepresented in the lower social classes, above all in the upper working class. With the exception of the diagnoses of (pre)senile dementia and other organic mental disorders, significant class differences were found. The lower the social class, the higher the rate of inpatient treatment (6 months' treated prevalence). The rate for the lower working class was especially high. The differences in class distribution between in-and outpatients are due primarily to those patients resident on 1 January 1971, mostly chronically ill, who, to a great extent, belong to the lower class. No significant difference exists between the social class distributions of inpatient and outpatient admissions, whether first or readmissions. In contrast to those under psychiatric treatment, and with the exception of the mentally retarded, we found no significant classspecific differences for patients in general practices. The rate of mental illnesses in need of treatment in the lower lower class in the field study was clearly higher than the expected value for the general population. The high rate in Class V is due to the diagnoses of mental retardation, alcoholism and neurotic/psychosomatic illnesses.This study was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft) within the research division Psychiatric Epidemiology (Sonderforschungsbereich 116, Psychiatrische Epidemiologie). Revised version of a paper presented at the 31st Congress of the Deutsche Gesellschaft für Psychologie in Mannheim, FRG, 17–21 September 1978.  相似文献   
8.
不同产地白术的多糖含量测定   总被引:2,自引:0,他引:2  
目的:对不同产地共8批白术的多糖含量进行了测定。方法:苯酚-硫酸比色法。结果:不同产地白术的多糖含量差异较大。结论:该法为白术的质量评价及质量控制提供了研究基础。  相似文献   
9.
Best病又称Best卵黄样黄斑营养不良(BVMD),是一种不规则的常染色体显性遗传性疾病,也有一些散发病例;临床特征是幼年或青年时期双眼黄斑部视网膜出现卵黄状的脂质样沉积物,而视力一般不受影响.随着病情发展,卵黄样物质逐渐吸收,开始出现视力波动.患者常在40岁左右时常发展为视网膜色素上皮(RPE)萎缩,黄斑部视网膜纤维瘢痕形成,以及继发性脉络膜新生血管(CNV)形成和视网膜下出血,最终出现视力严重的不可逆性损害.  相似文献   
10.
BackgroundAlpha-fetoprotein-producing gastric cancer (AFPGC) is a subtype of gastric cancer (GC) with more aggressive biological behavior. As a highly specific tight junction component exclusively present in gastric mucosa and gastric adenocarcinomas, claudin-18.2 (CLDN18.2) has become an emerging target in GC. In this study, we aimed to provide insight into AFPGC and investigate the expression and the clinical implications of CLDN18.2 in AFPGC.MethodsWe retrospectively collected 98 cases of AFPGC and reviewed their clinical, morphological, and immunohistochemical features. Another 356 patients with stage-matched conventional GC (cGC) were enrolled as a control group. We further surveyed CLDN18.2 expression by immunohistochemistry (IHC) in 51 AFPGC tissues and explained its association with the clinicopathological parameters of AFPGC.ResultsOur results showed that AFPGC was a unique GC type with elevated serum alpha-fetoprotein (AFP), which was a predictor of a worse prognosis. AFPGC showed typical morphological features and positive staining of at least 1 hepatocytic or enteroblastic marker. The expression rate of CLDN18.2 was low, with a positivity rate of 21.6%, which was much lower than that observed in cGC tissues (38.5%). A significant correlation was found between CLDN18.2 expression and the differentiation of AFPGC. CLDN18.2 expression was negatively correlated with the serum AFP level of AFPGC. We also found that AFPGC with a hepatoid type (HPT) component showed a significantly lower CLDN18.2 expression than those without.ConclusionsThis study demonstrated that CLDN18.2 was significantly decreased in AFPGC and was negatively correlated with the patient’s preoperative serum AFP level. The negative correlation between AFP and CLDN18.2 could be explained by retro-differentiation of AFPGC. Special treatment strategies might be needed for this unique tumor type.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号